Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$442K Sell
3,675
-551
-13% -$63.6K 0.09% 56
2025
Q4
$445K Sell
4,226
-50
-1% -$4.69K 0.09% 58
2025
Q3
$359K Buy
4,276
+985
+30% +$81.1K 0.08% 59
2025
Q2
$261K Hold
3,291
0.06% 65
2025
Q1
$295K Hold
3,291
0.08% 56
2024
Q4
$324K Hold
3,291
0.09% 57
2024
Q3
$374K Hold
3,291
0.1% 57
2024
Q2
$407K Buy
3,291
+600
+22% +$77.3K 0.12% 54
2024
Q1
$355K Hold
2,691
0.1% 56
2023
Q4
$293K Hold
2,691
0.09% 56
2023
Q3
$277K Buy
2,691
+62
+2% +$6.68K 0.09% 55
2023
Q2
$303K Hold
2,629
0.1% 55
2023
Q1
$280K Buy
+2,629
New +$284K 0.1% 55

Other funds holding MRK

Noble Family Wealth's MRK Position: Q1 2026 in Review

Noble Family Wealth reduced its Merck (MRK) stake by 13% in Q1 2026, selling an estimated $63.6K and leaving 3,675 shares worth $442K. The position accounts for 0.09% of the portfolio, ranked #56.

Noble Family Wealth first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. The position peaked at $445K in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Noble Family Wealth held 3,675 shares of Merck worth $442K as of Q1 2026.
  • Noble Family Wealth sold 551 Merck shares in Q1 2026, an estimated $63.6K.
  • Merck made up 0.09% of Noble Family Wealth's portfolio in Q1 2026, its #56 holding.
  • Noble Family Wealth first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • Noble Family Wealth's Merck position peaked at $445K in Q4 2025.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Noble Family Wealth's 13F filing for Q1 2026, filed 9 Apr 2026.